Your browser doesn't support javascript.
loading
Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer.
Goodwin, Pamela J; Chen, Bingshu E; Gelmon, Karen A; Whelan, Timothy J; Ennis, Marguerite; Lemieux, Julie; Ligibel, Jennifer A; Hershman, Dawn L; Mayer, Ingrid A; Hobday, Timothy J; Bliss, Judith M; Rastogi, Priya; Rabaglio-Poretti, Manuela; Thompson, Alastair M; Rea, Daniel W; Stos, Paul M; Shepherd, Lois E; Stambolic, Vuk; Parulekar, Wendy R.
Affiliation
  • Goodwin PJ; Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, and Department of Medicine, University of Toronto, Toronto, ON, Canada.
  • Chen BE; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
  • Gelmon KA; University of British Columbia, BC Cancer Agency, Vancouver, BC, Canada.
  • Whelan TJ; McMaster University, Juravinski Cancer Centre, Hamilton, ON, Canada.
  • Ennis M; Applied Statistician, Markham, ON, Canada.
  • Lemieux J; CHU de Québec-Université Laval, Québec, QC, Canada.
  • Ligibel JA; Dana-Farber Cancer Institute, Boston, MA.
  • Hershman DL; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY.
  • Mayer IA; Vanderbilt University, Nashville, TN.
  • Hobday TJ; Mayo Clinic, Rochester, MN.
  • Bliss JM; ICR-CTSU, Institute of Cancer Research (UK), London, United Kingdom.
  • Rastogi P; NRG Oncology and University of Pittsburgh Medical Center, Pittsburgh, PA.
  • Rabaglio-Poretti M; IBCSG and Department of Oncology, Bern University Hospital, University of Bern, Berne, Switzerland.
  • Thompson AM; Baylor College of Medicine, Houston, TX.
  • Rea DW; Cancer Research UK Clinical Trials Unit (CRCTU), Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
  • Stos PM; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
  • Shepherd LE; Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada.
  • Stambolic V; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Parulekar WR; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
J Clin Oncol ; 41(35): 5356-5362, 2023 Dec 10.
Article in En | MEDLINE | ID: mdl-37695982
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Metformin Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans Country/Region as subject: America do norte Language: En Journal: J Clin Oncol Year: 2023 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Metformin Type of study: Clinical_trials / Prognostic_studies Limits: Female / Humans Country/Region as subject: America do norte Language: En Journal: J Clin Oncol Year: 2023 Document type: Article Affiliation country: Canadá Country of publication: Estados Unidos